Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis.

Sturkenboom MG, Mulder LW, de Jager A, van Altena R, Aarnoutse RE, de Lange WC, Proost JH, Kosterink JG, van der Werf TS, Alffenaar JW.

Antimicrob Agents Chemother. 2015 Aug;59(8):4907-13. doi: 10.1128/AAC.00756-15. Epub 2015 Jun 8.

2.

Investigating the Lived Experience of Recovery in People Who Hear Voices.

de Jager A, Rhodes P, Beavan V, Holmes D, McCabe K, Thomas N, McCarthy-Jones S, Lampshire D, Hayward M.

Qual Health Res. 2016 Aug;26(10):1409-23. doi: 10.1177/1049732315581602. Epub 2015 Apr 20.

PMID:
25896792
3.

Size and molecular flexibility of sugars determine the storage stability of freeze-dried proteins.

Tonnis WF, Mensink MA, de Jager A, van der Voort Maarschalk K, Frijlink HW, Hinrichs WL.

Mol Pharm. 2015 Mar 2;12(3):684-94. doi: 10.1021/mp500423z. Epub 2015 Jan 26.

PMID:
25581526
4.

LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine--an Australian perspective.

de Jager AD, Warner JV, Henman M, Ferguson W, Hall A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 15;897:22-31. doi: 10.1016/j.jchromb.2012.04.002. Epub 2012 Apr 9.

PMID:
22521213
5.

Online extraction LC-MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone.

de Jager AD, Bailey NL.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 1;879(25):2642-52. doi: 10.1016/j.jchromb.2011.07.029. Epub 2011 Jul 30.

PMID:
21839693
6.

Drivers of land use change and household determinants of sustainability in smallholder farming systems of Eastern Uganda.

Ebanyat P, de Ridder N, de Jager A, Delve RJ, Bekunda MA, Giller KE.

Popul Environ. 2010 Jul;31(6):474-506. Epub 2010 Mar 6.

7.

Psychosocial dysfunction in the first year after Guillain-Barré syndrome.

Bernsen RA, de Jager AE, Kuijer W, van der Meché FG, Suurmeijer TP.

Muscle Nerve. 2010 Apr;41(4):533-9. doi: 10.1002/mus.21536.

PMID:
19941334
8.

Analysis of perfluorooctanoate (PFOA) and other perfluorinated compounds (PFCs) in the River Po watershed in N-Italy.

Loos R, Locoro G, Huber T, Wollgast J, Christoph EH, de Jager A, Manfred Gawlik B, Hanke G, Umlauf G, Zaldívar JM.

Chemosphere. 2008 Mar;71(2):306-13. Epub 2007 Oct 23.

PMID:
17959224
9.

Overdiagnosis of malaria in hospitalized patients in Namibia.

Van Dillen J, De Jager AJ, De Jong I, Wendte JF.

Trop Doct. 2007 Jul;37(3):185-6. No abstract available.

PMID:
17716517
10.

E-governance in the developing world in action: the case of DistrictNet in Uganda.

Van Reijswoud V, De Jager A.

World Hosp Health Serv. 2007;43(1):32-41.

PMID:
17621772
11.

Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis.

Roepman P, de Jager A, Groot Koerkamp MJ, Kummer JA, Slootweg PJ, Holstege FC.

Cancer Res. 2006 Dec 1;66(23):11110-4.

12.

Multiple fiber laser-induced thermotherapy for ablation of large intrahepatic tumors.

Veenendaal LM, de Jager A, Stapper G, Borel Rinkes IH, van Hillegersberg R.

Photomed Laser Surg. 2006 Feb;24(1):3-9.

PMID:
16503781
13.

The effects of Guillain-Barré syndrome on the close relatives of patients during the first year.

Bernsen RA, de Jager AE, van der Meché FG, Suurmeijer TP.

J Neurol Sci. 2006 May 15;244(1-2):69-75. Epub 2006 Feb 14.

PMID:
16476450
14.

Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients.

Badrising UA, Maat-Schieman ML, van Houwelingen JC, van Doorn PA, van Duinen SG, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, Verschuuren JJ, Wintzen AR.

J Neurol. 2005 Dec;252(12):1448-54. Epub 2005 Jun 17.

PMID:
15942703
15.

How Guillain-Barre patients experience their functioning after 1 year.

Bernsen RA, de Jager AE, van der Meché FG, Suurmeijer TP.

Acta Neurol Scand. 2005 Jul;112(1):51-6.

PMID:
15932357
16.

The eHealth Behavior Management Model: a stage-based approach to behavior change and management.

Bensley RJ, Mercer N, Brusk JJ, Underhile R, Rivas J, Anderson J, Kelleher D, Lupella M, de Jager AC.

Prev Chronic Dis. 2004 Oct;1(4):A14. Epub 2004 Sep 15.

17.

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.

Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group.

Neurology. 2004 Dec 28;63(12):2396-8.

PMID:
15623710
18.

Magnetic resonance imaging of single rice kernels during cooking.

Mohoric A, Vergeldt F, Gerkema E, de Jager A, van Duynhoven J, van Dalen G, Van As H.

J Magn Reson. 2004 Nov;171(1):157-62.

PMID:
15504695
19.

Muscle ultrasound analysis: normal values and differentiation between myopathies and neuropathies.

Maurits NM, Bollen AE, Windhausen A, De Jager AE, Van Der Hoeven JH.

Ultrasound Med Biol. 2003 Feb;29(2):215-25.

PMID:
12659909
20.

Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma.

Wiesner JL, de Jager AD, Sutherland FC, Hundt HK, Swart KJ, Hundt AF, Els J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 25;785(1):115-21.

PMID:
12535844
21.

Amorphous and condensed organic matter domains: the effect of persulfate oxidation on the composition of soil/sediment organic matter.

Cuypers C, Grotenhuis T, Nierop KG, Franco EM, de Jager A, Rulkens W.

Chemosphere. 2002 Sep;48(9):919-31.

PMID:
12222787
22.

Long-term impact on work and private life after Guillain-Barré syndrome.

Bernsen RA, de Jager AE, Schmitz PI, van der Meché FG.

J Neurol Sci. 2002 Sep 15;201(1-2):13-17.

PMID:
12163188
23.

Extractionless and sensitive method for high-throughput quantitation of cetirizine in human plasma samples by liquid chromatography-tandem mass spectrometry.

de Jager AD, Hundt HK, Swart KJ, Hundt AF, Els J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 25;773(2):113-8.

PMID:
12031836
24.

Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.

Badrising UA, Maat-Schieman ML, Ferrari MD, Zwinderman AH, Wessels JA, Breedveld FC, van Doorn PA, van Engelen BG, Hoogendijk JE, Höweler CJ, de Jager AE, Jennekens FG, Koehler PJ, de Visser M, Viddeleer A, Verschuuren JJ, Wintzen AR.

Ann Neurol. 2002 Mar;51(3):369-72.

PMID:
11891832
25.

Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma.

van Rooyen GF, Smit MJ, De Jager AD, Hundt HK, Swart KJ, Hundt AF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Mar 5;768(2):223-9.

PMID:
11890168
26.

Functional imaging of plants: a nuclear magnetic resonance study of a cucumber plant.

Scheenen T, Heemskerk A, de Jager A, Vergeldt F, Van As H.

Biophys J. 2002 Jan;82(1 Pt 1):481-92.

27.

Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings.

Kuipers-Upmeijer J, de Jager AE, Hew JM, Snoek JW, van Weerden TW.

J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):615-20.

28.

Activity and concentration of polyphenolic antioxidants in apple: effect of cultivar, harvest year, and storage conditions.

van der Sluis AA, Dekker M, de Jager A, Jongen WM.

J Agric Food Chem. 2001 Aug;49(8):3606-13.

PMID:
11513636
29.

Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma.

Sutherland FC, Badenhorst D, de Jager AD, Scanes T, Hundt HK, Swart KJ, Hundt AF.

J Chromatogr A. 2001 Apr 20;914(1-2):45-51.

PMID:
11358229
30.

Sensitive liquid chromatography-tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma.

Sutherland FC, de Jager AD, Badenhorst D, Scanes T, Hundt HK, Swart KJ, Hundt AF.

J Chromatogr A. 2001 Apr 20;914(1-2):37-43.

PMID:
11358228
31.

Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide.

Eurelings M, Moons KG, Notermans NC, Sasker LD, De Jager AE, Wintzen AR, Wokke JH, Van den Berg LH.

Neurology. 2001 Jan 23;56(2):228-33.

PMID:
11160960
32.

Comparison of serum S-100 protein levels following stroke and traumatic brain injury.

Elting JW, de Jager AE, Teelken AW, Schaaf MJ, Maurits NM, van der Naalt J, Sibinga CT, Sulter GA, De Keyser J.

J Neurol Sci. 2000 Dec 1;181(1-2):104-10.

PMID:
11099719
33.

Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.

Badrising UA, Maat-Schieman M, van Duinen SG, Breedveld F, van Doorn P, van Engelen B, van den Hoogen F, Hoogendijk J, Höweler C, de Jager A, Jennekens F, Koehler P, van der Leeuw H, de Visser M, Verschuuren JJ, Wintzen AR.

Neurology. 2000 Nov 14;55(9):1385-7.

PMID:
11087787
34.

Transthyretin Val71Ala mutation in a Dutch family with familial amyloidotic polyneuropathy.

Haagsma EB, Scheffer H, Altland K, De Jager AE, Hazenberg BP.

Amyloid. 2000 Sep;7(3):218-21.

PMID:
11019863
35.

Determination of doxepin and desmethyldoxepin in human plasma using liquid chromatography-tandem mass spectrometry.

Badenhorst D, Sutherland FC, de Jager AD, Scanes T, Hundt HK, Swart KJ, Hundt AF.

J Chromatogr B Biomed Sci Appl. 2000 May 26;742(1):91-8.

PMID:
10892587
36.

Extractionless determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by high-performance liquid chromatography.

de Jager AD, Hundt HK, Hundt AF, Swart KJ, Knight M, Roberts J.

J Chromatogr B Biomed Sci Appl. 2000 Apr 14;740(2):247-51.

PMID:
10821411
37.

Determination of linsidomine in human plasma by tandem LC-MS with ESI.

Sutherland FC, de Jager AD, Swart KJ, Hundt HK, Scanes T, Hundt AF.

J Pharm Biomed Anal. 2000 Apr;22(3):461-7.

PMID:
10766363
38.

Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection.

de Maar EF, Kas-Deelen DM, de Jager AE, The H, Tegzess AM, van Son WJ.

Nephrol Dial Transplant. 1999 Sep;14(9):2228-30. No abstract available.

PMID:
10489240
39.

Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome.

Bernsen RA, de Jager AE, Schmitz PI, van der Meché FG.

Neurology. 1999 Jul 22;53(2):409-10.

PMID:
10430437
40.

High-performance liquid chromatographic determination with amperometric detection of piroxicam in human plasma and tissues.

de Jager AD, Ellis H, Hundt HK, Swart KJ, Hundt AF.

J Chromatogr B Biomed Sci Appl. 1999 Jun 11;729(1-2):183-9.

PMID:
10410941
41.

Determination of ammonia in cerebrospinal fluid using the indophenol direct method.

Huizenga JR, Teelken AW, Tangerman A, de Jager AE, Gips CH, Jansen PL.

Mol Chem Neuropathol. 1998 Jun-Aug;34(2-3):169-77.

PMID:
10327416
42.

Cobalt-57 as a SPET tracer in the visualization of ischaemic brain damage in patients with middle cerebral artery stroke.

Stevens H, Knollema S, Piers DA, Van de Wiele C, Jansen HM, De Jager AE, De Reuck J, Dierckx RA, Korf J.

Nucl Med Commun. 1998 Jun;19(6):573-80.

PMID:
10234662
43.

Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke.

Stevens H, Jakobs C, de Jager AE, Cunningham RT, Korf J.

Eur J Clin Invest. 1999 Jan;29(1):6-11.

PMID:
10092982
44.

Painful Horner syndrome due to arteritis of the internal carotid artery.

Bollen AE, Krikke AP, de Jager AE.

Neurology. 1998 Nov;51(5):1471-2.

PMID:
9818886
45.

Rhesus anti-D immunoglobulin in chronic autoimmune neuropathy.

de Jager AE, Hazenberg CA, van der Hoeven JH.

Acta Neurol Scand. 1998 Jul;98(1):64-6.

PMID:
9696530
46.

Occurrence of the NIH shift upon the cytochrome P450-catalyzed in vivo and in vitro aromatic ring hydroxylation of fluorobenzenes.

Koerts J, Soffers AE, Vervoort J, De Jager A, Rietjens IM.

Chem Res Toxicol. 1998 May;11(5):503-12.

PMID:
9585481
47.

Muscle computed tomography in adult-onset acid maltase deficiency.

de Jager AE, van der Vliet TM, van der Ree TC, Oosterink BJ, Loonen MC.

Muscle Nerve. 1998 Mar;21(3):398-400.

PMID:
9486870
48.

Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndrome.

Ter Bruggen JP, van der Meché FG, de Jager AE, Polman CH.

Muscle Nerve. 1998 Feb;21(2):239-42.

PMID:
9466601
49.

Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis.

Heeringa P, van Goor H, Moshage H, Klok PA, Huitema MG, de Jager A, Schep AJ, Kallenberg CG.

Kidney Int. 1998 Feb;53(2):382-93.

50.

Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients.

Linssen WH, Notermans NC, Van der Graaf Y, Wokke JH, Van Doorn PA, Höweler CJ, Busch HF, De Jager AE, De Visser M.

Brain. 1997 Nov;120 ( Pt 11):1989-96.

PMID:
9397016

Supplemental Content

Loading ...
Support Center